Crossmark

Investigation of the antimycobacterial potential and toxicity evaluation of a proteinaceous compound from Streptomyces qinglanensis VITABS23 against Mycobacterium tuberculosis strains

Crossref DOI link: https://doi.org/10.1186/s41182-025-00859-6

Published Online: 2025-12-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Babu, Apsara S.

Rao, K. V. Bhaskara
Funding

Funding for this research was provided by:

Vellore Institute of Technology, Vellore
License Information

Text and Data Mining valid from 2025-12-19

Version of Record valid from 2025-12-22
More Information

Article History

Received: 18 September 2025

Accepted: 21 November 2025

First Online: 19 December 2025

Declarations

:

: All the methods were followed in this animal study after prior IAEC approval from the Institutional Animal Ethical Committee (IAEC) clearance (VIT/IAEC-26/17April/24/14).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below